Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Skye Bioscience, Inc.
SKYE
Other
Nasdaq Minimum Bid Price Delisting Notice
Core
Management Exodus
Other
New York Jurisdiction Clause
Market Price Definition
Corporate Authority Representation
Amendment Modification Waiver Clause
Corporate Organization And Standing Representation
Indemnification Consent Requirement
Conflicted Defense Counsel Provision
Form 8K Filing Disclosure
Survival Of Representations Warranties Clause
Fcpa Compliance Representation
Registration Rights Piggyback Provision
No Broker Fees Representation
Closing Deliverables Specified
Registrant Bears Registration Expenses
Stock Option Exercise Payment Method Disclosure
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Corporate Organization And Standing Representation
Reverse Stock Split Effected
Merger Proxy Statement Disclosure
Indemnification Consent Requirement
Earnings Call Qa Segment
Corporate Authority Representation
Fcpa Compliance Representation
Interim Data Positive
Registration Rights Piggyback Provision
Sanctions Compliance Representation
Amendment Modification Waiver Clause
Hazardous Materials Definition
Conflicted Defense Counsel Provision
Board Committee Member Listing
Core
Clinical Trial Result
Other
Reverse Stock Split Effected
Nyse Listing Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Market Volatility Risk Disclosure
Net Loss Reported
Stock Price As Of Filing Date
Other Income Expense Disclosure
Restrictive Debt Covenants Disclosure
Competition Disclosure
Goodwill Impairment
Capital Raising Uncertainty Disclosed
Personnel Cost Decrease Disclosure
Cash Flow Statement Investing Activities
Shares Outstanding Disclosure
Administrative Efficiency
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Say On Pay Vote Result Disclosed
Classified Board Director Election
Adjournment Proposal Voting Requirement
Equity Plan Board Approval Conditional On Shareholder Vote
Quorum Presence Disclosed
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Nyse Listing Disclosure
Net Loss Reported
Capital Raising Uncertainty Disclosed
Reverse Stock Split Effected
Other Income Expense Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Cash Flow Statement Investing Activities
Personnel Cost Decrease Disclosure
Shares Outstanding Disclosure
Interim Data Positive
Financing Activities Cash Flow Disclosure
Burn Rate Controlled
Administrative Efficiency
Core
Clinical Trial Result
Indication Expansion
Other
Executive Educational Background Disclosure
Confidential Information Return Obligation
Non Assignment Clause
Termination For Material Breach Clause
New York Jurisdiction Clause
Non Solicitation Covenant
Amendment Modification Waiver Clause
Indemnification Consent Requirement
Registrant Bears Registration Expenses
Director Officer Indemnification Provision
Transfer And Demand Rights Limitations
Stock Option Grant Disclosed
Conflicted Defense Counsel Provision